TD Asset Management Inc Has $57.49 Million Stock Holdings in Cardinal Health, Inc. $CAH

TD Asset Management Inc lowered its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.5% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 342,224 shares of the company's stock after selling 5,126 shares during the period. TD Asset Management Inc owned approximately 0.14% of Cardinal Health worth $57,494,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of CAH. RFG Advisory LLC grew its position in shares of Cardinal Health by 12.0% in the second quarter. RFG Advisory LLC now owns 3,423 shares of the company's stock valued at $575,000 after purchasing an additional 368 shares during the last quarter. Axxcess Wealth Management LLC grew its holdings in Cardinal Health by 47.9% in the 2nd quarter. Axxcess Wealth Management LLC now owns 15,307 shares of the company's stock valued at $2,572,000 after buying an additional 4,958 shares in the last quarter. Moran Wealth Management LLC bought a new position in Cardinal Health during the 2nd quarter worth $229,000. Sequoia Financial Advisors LLC increased its position in Cardinal Health by 11.4% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 8,946 shares of the company's stock worth $1,503,000 after buying an additional 916 shares during the period. Finally, Bill Few Associates Inc. acquired a new stake in shares of Cardinal Health during the second quarter worth $216,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $155.72 on Thursday. Cardinal Health, Inc. has a 1 year low of $106.98 and a 1 year high of $168.44. The stock has a market capitalization of $37.00 billion, a price-to-earnings ratio of 24.14, a price-to-earnings-growth ratio of 1.30 and a beta of 0.71. The company's 50 day simple moving average is $151.90 and its 200 day simple moving average is $151.48.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the business posted $1.84 EPS. The company's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's payout ratio is presently 31.63%.

Insider Transactions at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. This represents a 61.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Ola M. Snow sold 28,151 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms recently commented on CAH. Leerink Partners upped their price target on shares of Cardinal Health from $186.00 to $187.00 and gave the company an "outperform" rating in a research note on Monday, October 6th. UBS Group restated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 2nd. Robert W. Baird increased their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. Finally, Weiss Ratings restated a "buy (b)" rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.